Pet Pharm Biotech Co., Ltd. (TPEX: 7762)
Health Care · Biotechnology · TW
NT$55.60
+2.02% today · -29.8% 1Y
Pet Pharm Biotech Co., Ltd. (TPEX: 7762) operates in the Biotechnology industry within the Health Care sector. The company is valued at $101.01M.
Over the last twelve months the share price has lost 29.8%, trading between 44.00 and 82.07.
Tweenvest scores Pet Pharm Biotech Co., Ltd. across four factors: quality 83/100, value 55/100, dividend 10/100. Its strongest factor is quality.
7762 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $101.01M
- Revenue (TTM)
- $8.35M
- P/E
- 107.93
- EPS
- 0.52
- Dividend yield
- 0.44%
- Beta (5Y)
- 0.72
- 52-week high
- NT$82.07
- 52-week low
- NT$44.00
- Avg volume (3M)
- —
- Shares outstanding
- 58.09M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kintor Pharmaceutical LimitedSEHK: 9939 | $102.88M | HK$1.64 | -8.91% |
| ArcticZymes Technologies ASAOB: AZT | $102.18M | Nkr19.15 | -2.54% |
| Black Diamond Therapeutics, Inc.NasdaqGS: BDTX | $101.69M | $1.68 | -5.08% |
| TiumBio Co., Ltd.KOSDAQ: A321550 | $101.44M | ₩4,540.00 | +0.33% |
| Anixa Biosciences, Inc.NasdaqCM: ANIX | $100.82M | $2.67 | -7.93% |
| Faron Pharmaceuticals OyAIM: FARN | $99.76M | £0.37 | +5.19% |
| HST Global, Inc.OTCPK: HSTC | $99.00M | $0.70 | +600.00% |
| Biomea Fusion, Inc.NasdaqGS: BMEA | $98.58M | $1.26 | -7.35% |
Figures last refreshed Oct 11, 2026.